Dimensional Fund Advisors
TBPH icon

Dimensional Fund Advisors’s Theravance Biopharma TBPH Stock Holding History

Dimensional Fund Advisors’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16M Buy
983,615
+124,658
+15% +$2.21M ﹤0.01% 2077
2025
Q4 		$16.1M Buy
858,957
+92,253
+12% +$1.53M ﹤0.01% 2086
2025
Q3 		$11.2M Buy
766,704
+44,634
+6% +$564K ﹤0.01% 2263
2025
Q2 		$7.97M Buy
722,070
+78,232
+12% +$761K ﹤0.01% 2358
2025
Q1 		$5.75M Buy
643,838
+90,125
+16% +$839K ﹤0.01% 2459
2024
Q4 		$5.21M Buy
553,713
+95,304
+21% +$867K ﹤0.01% 2519
2024
Q3 		$3.69M Buy
458,409
+128,228
+39% +$1.11M ﹤0.01% 2611
2024
Q2 		$2.8M Buy
330,181
+91,679
+38% +$827K ﹤0.01% 2672
2024
Q1 		$2.14M Buy
238,502
+105,318
+79% +$976K ﹤0.01% 2780
2023
Q4 		$1.5M Buy
133,184
+61,564
+86% +$620K ﹤0.01% 2849
2023
Q3 		$617K Buy
71,620
+16
+0% +$154 ﹤0.01% 3020
2023
Q2 		$741K Buy
+71,604
New +$791K ﹤0.01% 2985
2016
Q4 		– Sell
-43,018
Closed -$1.56M – 3301
2016
Q3 		$1.56M Hold
43,018
– – ﹤0.01% 2841
2016
Q2 		$976K Sell
43,018
-474
-1% -$10.2K ﹤0.01% 2931
2016
Q1 		$817K Sell
43,492
-30
-0.1% -$491 ﹤0.01% 2961
2015
Q4 		$713K Buy
43,522
+20,004
+85% +$317K ﹤0.01% 3028
2015
Q3 		$258K Sell
23,518
-1,088
-4% -$13.9K ﹤0.01% 3212
2015
Q2 		$320K Sell
24,606
-4,472
-15% -$69.4K ﹤0.01% 3199
2015
Q1 		$505K Sell
29,078
-27
-0.1% -$495 ﹤0.01% 3101
2014
Q4 		$434K Sell
29,105
-15
-0.1% -$261 ﹤0.01% 3154
2014
Q3 		$671K Hold
29,120
– – ﹤0.01% 3098
2014
Q2 		$929K Buy
+29,120
New +$877K ﹤0.01% 3051

Other funds holding TBPH

MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ICM
Irenic Capital Management New York $1.54B AUM 12.79% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors's TBPH Position: Q1 2026 in Review

Dimensional Fund Advisors increased its Theravance Biopharma (TBPH) stake by 15% in Q1 2026, buying an estimated $2.21M and bringing the position to 983,615 shares worth $16M. The position accounts for ﹤0.01% of the portfolio, ranked #2077.

Dimensional Fund Advisors first reported a position in TBPH in Q2 2014 and has held it in 22 quarters since. The position peaked at $16.1M in Q4 2025. 173 funds tracked by Wall St. Rank hold TBPH as of Q1 2026.

  • Dimensional Fund Advisors held 983,615 shares of Theravance Biopharma worth $16M as of Q1 2026.
  • Dimensional Fund Advisors bought 124,658 Theravance Biopharma shares in Q1 2026, an estimated $2.21M.
  • Theravance Biopharma made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #2077 holding.
  • Dimensional Fund Advisors first reported a position in Theravance Biopharma in Q2 2014 and has held it in 22 quarters since.
  • Dimensional Fund Advisors's Theravance Biopharma position peaked at $16.1M in Q4 2025.
  • 173 funds tracked by Wall St. Rank held Theravance Biopharma as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.